Literature DB >> 7536617

CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses.

G D Ghadge1, R P Roos, U J Kang, R Wollmann, P S Fishman, A M Kalynych, E Barr, J M Leiden.   

Abstract

The ability to program recombinant gene expression in specific sets of motor and sensory neurons would facilitate the treatment of a number of acquired and inherited central nervous system (CNS) diseases. In this report, we demonstrate that intramuscular injection of replication-defective recombinant adenovirus results in high-level recombinant gene expression, specifically in the CNS motor and sensory neurons that innervate the inoculated muscles. Neural expression of the recombinant genes results from virus transport into the CNS, presumably by retrograde axonal transport. This novel method of neural gene delivery may be of value in studies designed to improve understanding and treatment of inherited and acquired neurological diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536617

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  21 in total

1.  Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system.

Authors:  M Glatzel; E Flechsig; B Navarro; M A Klein; J C Paterna; H Büeler; A Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Cytoplasmic dynein mediates adenovirus binding to microtubules.

Authors:  Samir A Kelkar; K Kevin Pfister; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 3.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

4.  Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.

Authors:  A Amalfitano; M A Hauser; H Hu; D Serra; C R Begy; J S Chamberlain
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population.

Authors:  B J Baumgartner; H D Shine
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

6.  Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system.

Authors:  L Coen; R Osta; M Maury; P Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.

Authors:  Valerie B O'Leary; Marie O'Connell; Inga Antyborzec; Vasilis Ntziachristos; J Oliver Dolly; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

8.  Phenotypic alteration of astrocytes induced by ciliary neurotrophic factor in the intact adult brain, As revealed by adenovirus-mediated gene transfer.

Authors:  F Lisovoski; S Akli; E Peltekian; E Vigne; G Haase; M Perricaudet; P A Dreyfus; A Kahn; M Peschanski
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

9.  Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice.

Authors:  S Millecamps; D Nicolle; I Ceballos-Picot; J Mallet; M Barkats
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

10.  Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.

Authors:  Chris Towne; Marie Pertin; Ahmed T Beggah; Patrick Aebischer; Isabelle Decosterd
Journal:  Mol Pain       Date:  2009-09-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.